NutryFarm International Ltd. logo

NutryFarm International Ltd. (AZT)

Market Closed
17 Jul, 09:00
S$
0. 09
0
0%
S$
- Market Cap
120.29 P/E Ratio
- Div Yield
79,800 Volume
0.44 Eps
S$ 0.09
Previous Close
Add Transaction
Day Range
0.09 0.09
Year Range
0.09 0.09
Want to track AZT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AZT closed Friday higher at S$0.09, an increase of 0% from Thursday's close, completing a monthly increase of 0% or S$0. Over the past 12 months, AZT stock gained 0%.
AZT is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0167%, based on the last three reports.
NutryFarm International Ltd. has completed 1 stock splits, with the recent split occurring on Jun 12, 2015.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

AZT Chart

NutryFarm International Ltd. (AZT) FAQ

What is the stock price today?

The current price is S$0.09.

On which exchange is it traded?

NutryFarm International Ltd. is listed on SGX.

What is its stock symbol?

The ticker symbol is AZT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has NutryFarm International Ltd. ever had a stock split?

NutryFarm International Ltd. had 1 splits and the recent split was on Jun 12, 2015.

NutryFarm International Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Ahmed Khaled El-Hoshy CEO
SGX Exchange
BMG6700D1048 ISIN
Norway Country
53 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

ArcticZymes Technologies ASA is a prominent life sciences company rooted in Tromsø, Norway, with operations spanning globally, including significant presences in Norway, Germany, Lithuania, Italy, the United States, and other parts of Europe. Initially founded in 1990 and known as Biotec Pharmacon ASA, the company underwent a rebranding to ArcticZymes Technologies ASA in June 2020. ArcticZymes specializes in developing, manufacturing, and commercializing recombinant enzymes for a wide range of applications including molecular research, in vitro diagnostics, and biomanufacturing. The company's innovative approach to enzyme technology underscores its commitment to facilitating advancements in the life sciences sector.

Products and Services

ArcticZymes Technologies ASA offers a diverse portfolio of specialized enzymes and related products designed to meet the rigorous demands of molecular research, diagnostics, and biomanufacturing. These products include:

  • Salt Active Nuclease: This enzyme is tailored for the removal of nucleic acids during the manufacturing of viral vectors, recombinant proteins, and other biological reagents, enhancing purity and yield in bioprocessing workflows.
  • Shrimp Alkaline Phosphatase: Optimized for the clean-up processes preceding Sanger sequencing and next-generation sequencing applications, ensuring high-quality results in genetic analysis.
  • Cod UNG (Uracil-DNA Glycosylase): Specifically designed for use in viral and other molecular diagnostic assays, this enzyme is instrumental in reducing the risk of carry-over contamination in PCR and qPCR workflows.
  • Double-Strand Specific DNases and Derived Kits: These products target the removal of double-stranded DNA, playing a crucial role in preventing contamination and improving the accuracy of molecular assays.
  • Polymerases: The company offers a range of polymerases suited for technology development applications across life science research, molecular diagnostics, next-generation sequencing (NGS), and synthetic biology, highlighting their versatility and high performance.
  • Proteinase: Designed for applications in microbiological diagnostics and liquid biopsies, this enzyme aids in the efficient breakdown of protein samples, facilitating easier analysis and detection of microbial and other biological entities.
  • Ligases: These enzymes are crucial for joining nucleic acids, enabling their use in various genetic engineering, sequencing, and molecular cloning applications, thereby supporting advanced research and development in genetics and biotechnology.

Contact Information

Address: Sykehusveien 23
Phone: 47 77 64 89 00